Pharsight

Drugs that contain Valganciclovir Hydrochloride

1. Valcyte patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9642911 HOFFMANN LA ROCHE Pharmaceutical dosage forms comprising valganciclovir hydrochloride
Dec, 2027

(4 years from now)

US8889109 HOFFMANN LA ROCHE Pharmaceutical dosage forms comprising valganciclovir hydrochloride
Dec, 2027

(4 years from now)

Market Authorisation Date: 28 August, 2009

Treatment: NA

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of VALCYTE before it's drug patent expiration?
More Information on Dosage

VALCYTE family patents

Family Patents